Monday 6 April 2020 ,
Monday 6 April 2020 ,
Latest News
  • PM’s stimulus package to save economy, livelihood, says FBCCI
  • Mayor Ivy seeks curfew or lockdown in NCC
  • Don’t leave or enter Dhaka until further notice: Police HQ
  • One more dies; 18 new patients detected
  • Coronavirus cases rise to 88; death toll now 9
  • Coronavirus: 2 buildings, one tin-shed house under lockdown in Mirpur
  • Coronavirus: Govt extends general holiday till April 14
  • Coronavirus: Biman cancels all flights until Apr 14
  • Corona fallout: PM unveils new stimulus packages of Tk 67,750 cr
  • Coronavirus Hotline Numbers: Hunting Number: 01944333222, DGHS: 16263, 333
12 March, 2018 00:00 00 AM
Print

‘Linaptin’ registered and launched by GPL in srilankan pharma market

Stethoscope desk
‘Linaptin’ registered and launched by GPL in srilankan pharma market

In the SAARC region, Srilanka has tremendous potentiality for exporting of pharmaceutical finished products from Bangladesh. In this regard General Pharmaceuticals Ltd. (GPL) had registered & launched its LINAGLIPTIN brand “LINAPTIN” on 18th February, 2018 for the 1st time in Srilankan Pharma market. “LINAPTIN” is also bioequivalent to the research brand. The launching program was held at Shangri-La Hotel, Colombo, Srilanka.

The renowned doctors (Endocrinologists, Nephrologists and Physicians) from all provinces of Srilanka had participated at this successful launch program. From General Pharma, Dr. Momenul Haq, Managing Director, Dr. Sarah Momen, Director, Dr. Ziad Rahman, Manager Global Marketing and Mahmudul Haque, Deputy Manager, Global Marketing participated.

Dr. Moemnul Haq, Managing Director of General Pharma, in his welcome speech highlighted Bangladesh Pharma Industry’s success and also elaborated General Pharma’s vision in regards to bringing new products for Sri Lanka. He thanked all the relevant authorities, companies for ensuring launching of Linaptin first time in Sri Lanka. Dr. Ziad Rahman presented company profile ta the attending doctors.

GPL started exporting pharmaceutical finished products in Srilanka market from 2007 onwards. So far, GPL has 27 registered products in this market and more number of products are under registration stage.

GPL is exporting of its pharmaceutical finished formulations to 26 countries along with Sri Lanka. The countries are Philippines, Vietnam, Hong Kong, Cambodia, Myanmar, Kenya, Ethiopia, Tanzania, Jamaica. Dominican Republic, Cameroon, Tchad, Afghansitan, Macau, Somalia, Bhutan, Burkina Faso, Libya, Yemen, Niger, Nigeria, Mauritius, Maldives, Belize & Guatemala. Another 14 countries are under development stage.

 

 

Comments

Most Viewed
Digital Edition
Archive
SunMonTueWedThuFri Sat
01020304
05060708091011
12131415161718
19202122232425
2627282930

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting